- Home
- ORLA vs LNTH Comparison
ORLA vs LNTH Comparison
Compare ORLA & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORLA
- LNTH
- Stock Information
- Founded
- ORLA 2007
- LNTH 1956
- Country
- ORLA Canada
- LNTH United States
- Employees
- ORLA N/A
- LNTH N/A
- Industry
- ORLA Precious Metals
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ORLA Basic Materials
- LNTH Health Care
- Exchange
- ORLA Nasdaq
- LNTH Nasdaq
- Market Cap
- ORLA 3.1B
- LNTH 3.8B
- IPO Year
- ORLA N/A
- LNTH 2015
- Fundamental
- Price
- ORLA $9.93
- LNTH $51.07
- Analyst Decision
- ORLA Buy
- LNTH Buy
- Analyst Count
- ORLA 1
- LNTH 6
- Target Price
- ORLA $27.00
- LNTH $74.50
- AVG Volume (30 Days)
- ORLA 2.6M
- LNTH 1.4M
- Earning Date
- ORLA 11-11-2025
- LNTH 11-06-2025
- Dividend Yield
- ORLA N/A
- LNTH N/A
- EPS Growth
- ORLA N/A
- LNTH N/A
- EPS
- ORLA 0.07
- LNTH 2.39
- Revenue
- ORLA $596,487,000.00
- LNTH $1,525,933,000.00
- Revenue This Year
- ORLA $182.00
- LNTH N/A
- Revenue Next Year
- ORLA $38.17
- LNTH $1.98
- P/E Ratio
- ORLA $126.04
- LNTH $21.34
- Revenue Growth
- ORLA 116.83
- LNTH 1.95
- 52 Week Low
- ORLA $3.81
- LNTH $47.25
- 52 Week High
- ORLA $13.91
- LNTH $111.29
- Technical
- Relative Strength Index (RSI)
- ORLA 41.77
- LNTH 36.35
- Support Level
- ORLA $9.41
- LNTH $54.76
- Resistance Level
- ORLA $10.57
- LNTH $61.92
- Average True Range (ATR)
- ORLA 0.48
- LNTH 2.36
- MACD
- ORLA -0.16
- LNTH -0.44
- Stochastic Oscillator
- ORLA 23.32
- LNTH 4.15
About ORLA Orla Mining Ltd.
Orla Mining Ltd is a mineral exploration company. It is engaged in the acquisition and exploration of mineral properties. The company holds three gold projects; the Camino Rojo gold and silver project in Zacatecas State, Musselwhite gold mine project located in Ontario and the South Railroad projects in Nevada, USA, and the Cerro Quema gold project in Panama. It conducts business activities in Mexico, Panama, the United States, and Canada.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.